Clinical Trials Browser

Disease, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02932280 2025-12-05

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Phase 1/2 Active not recruiting

14 enrolled

CNSLymphoidOther hematologic neoplasm

Disease, Leukemia, Lymphoma, Recurrence, Central Nervous System Neoplasms

NCT07075185 2025-09-02

inMMyCAR

Phase 1 Recruiting

40 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT05106192 2025-06-12

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

Phase NA Withdrawn

DermatologicLymphoid

Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphomatoid Papulosis

NCT06767956 2025-06-04

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy

Phase 1/2 Not yet recruiting

30 enrolled

Lymphoid

Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT04033627 2022-09-29

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

Phase NA Unknown

30 enrolled

LymphoidOther hematologic neoplasm

Disease, Graft vs Host Disease, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03429387 2022-05-17

PIPPIN

Phase NA Completed

147 enrolled

Classical hematologyLymphoidOther hematologic neoplasm

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT01613300 2021-05-26

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

Phase 2 Completed

33 enrolled

Lymphoid

Disease, Lymphoma, B-Cell

NCT03755947 2021-02-02

Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

Phase 2 Completed

3 enrolled

LymphoidOther hematologic neoplasm

Disease, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03185494 2019-04-17

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22

Phase 1/2 Unknown

30 enrolled

LymphoidOther hematologic neoplasm

Disease, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT03312205 2019-01-09

CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

Phase 1/2 Unknown

50 enrolled

LymphoidOther hematologic neoplasm

Disease, Leukemia, Lymphoma

NCT02337140 2016-12-01

TAVISTIM

Phase NA Completed

165 enrolled

Lymphoid

Aortic Valve Stenosis, Disease, Lymphoma, Follicular

NCT00748319 2012-08-22

KIR

Phase NA Completed

495 enrolled

DermatologicLymphoid

Dermatitis, Dermatitis, Exfoliative, Disease, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Clinical Trials

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

inMMyCAR

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

PIPPIN

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22

CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

TAVISTIM

KIR